跳至主要内容
临床试验/IRCT20240506061675N1
IRCT20240506061675N1招募中3 期

Investigating the effect of Oral capsule of Ziziphora tenuior plant extract on Primary Dysmenorrhoea

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 94 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 30 years(—)
性别
Female

入选标准

  • Have no children
  • Participants must be between the ages of 18 and 30.
  • According to the statement of the person suffering from a known chronic disease such as Diabetes, Hypertension, Underlying heart disease, Infectious disease, liver disease, kidney disease, Epilepsy and Malignancy
  • She has not taken any medication since three months before the intervention.
  • Do not use special drugs or supplements
  • According to the person's statement, she does not have any symptoms such as burning, itching or abnormal secretions from the Vagina and Cervix
  • Have regular cycles from 22 to 35.
  • Body mass index should be between 19.8 and 26.
  • Have a history of primary dysmenorrhoea according to the Visual analog scale during the last 6 months
  • Students living in Shahid Beheshti Medical Sciences student dormitories in Tehran
  • The amount of bleeding should be between 3 and 7 days
  • No bleeding between periods.
  • There should be no stressful events such as the death of relatives and surgery in the last 6 months.
  • Do not smoke or drink alcohol.
  • There is no history of Uterine disorders (Myoma, Bicornuate uterus, Polyps), Ovarian disorders (Ovarian Cyst and Polycystic ovary) or Endometrial hypertrophy and Endometriosis according to recent ultrasounds.

排除标准

  • Take any herbal medicine while studying.
  • Participants do not want to continue treatment.
  • Kidney or liver disease or cases that, according to the doctor's opinion, should stop treatment, appear during the research.
  • Failure to correctly use Ziziphora tenuior capsules or placebo, less than 7 capsules in the first three days of menstruation.

研究者

相似试验